Novo Nordisk considers upgrading its New York listing to boost its U.S. profile
智通财经2026/09/23 04:21Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to the Financial Times: Novo Nordisk (NVO.US) does not rule out upgrading its listing status in New York, a move aimed at enhancing the Danish weight-loss drug manufacturer's visibility in the US market. Previously, its British competitor AstraZeneca took a similar step earlier this year.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$86,219.2
+0.83%
Ethereum
ETH
$2,748.23
+0.59%
Tether USDt
USDT
$0.9999
+0.01%
BNB
BNB
$789.32
+0.31%
XRP
XRP
$1.62
+6.40%
USDC
USDC
$1.0000
+0.00%
Solana
SOL
$118.15
+1.65%
TRON
TRX
$0.3439
-1.27%
Zcash
ZEC
$1,627.41
+7.90%
Hyperliquid
HYPE
$96.39
+1.90%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now